MOLECULAR GENETICS IN CHILDHOOD ACUTE LEUKEMIA (AND THEIR IMPLICATION IN THE MANAGEMENT

Rasha Mohamed EI-Sayed Abd-EI-Motagaly;

Abstract


Dispite significant improvement of leukemia treatment on past two decides, about one third of children treated for acute leukemia relapse. No individual predictive factor has yet been found to identify this subgroup of patients.

Remarkable advances have been made m our understanding of molecular pathogenesis of acute leukemia with cytogeltics and molecular genetic data guiding successive improvement in treatment and risk prediction.

Since most of relapses stem from cells of original leukemic clone, assment of minimal residual disease may help to evaluate the efficacy of therapy, predict impending relapse and alternatively permit individualization of therapeutic protocol.

As the overall gall of therapy is eradication of!eukemic clone and restoration of normal hematopoises, this is usually accomplished through use of myelosuppressive chemotherapy. During the last few year new idias was found for treatment such as gene therapy, monoclonal antibodies therapy, ATRA in promyelocytic leukemia and arsinic trioxide.

Key Words: Childhood acute leukemia cytogenitices, minimal residual disease prognostic factors, treatment, new ideas of treatment.


Other data

Title MOLECULAR GENETICS IN CHILDHOOD ACUTE LEUKEMIA (AND THEIR IMPLICATION IN THE MANAGEMENT
Other Titles دراسة بحثية عن الجينات الجزيئية فى مرض اللوكيما الحادة عند الاطفال وتأثيرها فى خطة العلاج
Authors Rasha Mohamed EI-Sayed Abd-EI-Motagaly
Issue Date 2002

Attached Files

File SizeFormat
رشا محمد السيد.pdf847.36 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.